
â æã ãèªç¶ã»çç©çãšããã¹ç°å¢ãšã®ãã倿§ã§äžåºžãªé¢ä¿ãåéèŠãããã¹ãæä»£ãšãªããïŒ( Cf.ã»ã»ã»ããã«ãã颚éªã³ãããŠã€ã«ã¹ã«å ±éã®äœããã®æåãèªèããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èãç²åŸïŒã®å¯ããïŒ)
â æã
ãèªç¶ã»çç©çãšããã¹ç°å¢ãšã®ãã倿§ã§äžåºžãªé¢ä¿ãåéèŠã®æä»£ãšãªã鎚ç¥ç€ŸïŒãâ Cf.éå»ã®é¢šéªã®å
ç«èšæ¶ãæ°åã³ããããäžçãæãïŒããã«ãã颚éªã³ãããŠã€ã«ã¹ã«å
±éã®äœããã®æåãèªèããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èãç²åŸïŒã®å¯ããïŒ819æ¥çµãã€ãªãã¯https://twitter.com/tadanoossan2/status/1292695385794727943
ïŒæ³šèšïŒãšããã¹ãšã¯ïŒ
ã»ã»ã»ã»ã»ã»äžç倧çŸç§äºå žç¬¬ïŒçïŒå¹³å¡ç€ŸïŒã®èª¬æã«ããã°ãããããã®ãšããã¹(ethnos)ã¯ã®ãªã·ã¢èªã§æ°æãæå³ãããæ°ä¿åŠã®çšèªãšããŠã¯ããã·ã¢ç³»ã®æ°ä¿åŠè S.M.ã·ãã³ãŽãããã¯ãããŠæ¬æ Œçã«è«ãïŒãã€ãã®æ°ä¿åŠè ãã¥ãŒã«ãã³ïŒW.E.MÃŒhlmannïŒ1904â )ãªã©ã«ãã£ãŠããã®æŠå¿µã®éèŠæ§ãæããã«ããããããã¯ãåäžã®æåçäŒçµ±ãå ±æãããšãšãã«ãããããäœã æãäœã 人ããšããå ±å±æèããã€æå€§ã®ç¬ç«ããåäœéå£ãæãã
ã»ã»ã»åŸã£ãŠïŒãäžã€ã®ãšããã¹ã¯å Žåã«ãã£ãŠã¯ïŒãã³ãã§ãïŒæ°æã§ãïŒéšæã§ãïŒãããã¯ã«ãŒã¹ãã§ããããããããšããããšã«ãªãããããã§ã¯ãã®åŸã®èªç¶ç§åŠãæŽå²ãå°çç°å¢ãæ°æã»äººé¡åŠçã«é¢ããç ç©¶ãšäººé瀟äŒã®å šè¬ã«ä¿ããæèäžã®å€åçãåæ ããã€ã€ãæŽã«æ¹å€å®åšè«ïŒCritical RealismïŒãæ°å®åšè«ïŒæ°å®å䞻矩ïŒãªã©ã®æ°ããªèŠç¹ãå å³ããŠãšããã¹ã®æŠå¿µãåå®çŸ©ããŠããããšã«ããã
ã»ã»ã»ããã§ã次ã®ããã«å®çŸ©ããããšãå¯èœãšãªãã ãããããªãã¡ãethnosã¯å€ä»£ã®ãªã·ã¢èªã«ç±æ¥ããŠãããæãéœåžã«éäœãããæ°è¡ãïŒãã¢ã¹ïŒdemosïŒã®åšèŸºã«äœã¿ããã®ãæ°è¡ã以å€ã®éšæéå£ã®ããšãæå³ããããšããããšããã¹ã®æå³ã¯ãããã«çœ®ããã人ã ã®ç«ã¡äœçœ®ãå€ããã°æ£å察ã«å転ãåŸãããšã«ãªãã®ã§ããããã絶察çã§ç»äžçãªäŸ¡å€è©äŸ¡ã䌎ãèšèã§ã¯ãªãã£ããšããããšã«ãªãã
ã»ã»ã»ãããããããã¯äŒãããšãªãäžåçã®é£ç¶ã§ãããçåœãçŸè±¡ãã®ãã®ãšåãããæ°žé ã«æºããã€ã€ãïŒå¯Ÿè±¡ãšèæ¯ç°å¢ãçµ¶ãã亀æ¿ãåŸããã®ã§ãããããïŒåã¢ã€ãã³ãã£ãã£ãŒã®æç¶æ§ãå¿ æ»ã§ç¹ããšããã¹ããã®ã§ãããšèšããã®ã§ã¯ãªããããã
ã»ã»ã»åŸã£ãŠããšããã¹ãšã¯ã人éã®çåœãšç€ŸäŒç掻ã®ç¶æã«å¿ é ãšãªãäžå®ã®ããŒã«ã«å°åã®èªç¶ã»æŽå²ã»æåç°å¢ãšæ·±ãå ±é³ŽããŠâäººéæ§ãæªçïŒæªæ¥ïŒãžç¹ãæºãç± âïŒå¹å°ïŒãšãªãåŸãéæŸç³»ã®å ±æèŠ³å¿µãããã³é¢šåãŸãã¯éå»ãçŸåšãæªæ¥ã«æž¡ãçåç°å¢ã®åŸ®å°éŠŽåïŒãã€ã¯ããã€ãªãŒã ãéåç©çåŠããããã¯ãšããžã§ããã£ãã¯ããã©ã³ã¹ãªãã¯ã¹ãªã©å®éšå»åŠé åã«ãããå€å±€çåœç§åŠã®ããã³ãã£ã¢ãªã©ïŒãåžžã«åãå ¥ãã€ã€ãããã®äŒçµ±çãªãã¥ãŒãã³ã»ã¹ã±ãŒã«ã®å šäœæ§ã®âæç¶âãæãéèŠãããéåžžã«ããªããã§å¹ ãåºãå¯å®¹ã®æèãããã³ãã®åãç¿ãšãªãããŒã«ã«ã®é¢šåããæå³ãããïŒãšããããšã«ãªããïŒä»¥äžãhttps://toxandoria.hatenadiary.jp/entry/2020/06/04/155449ããéšå転èŒïŒ
ïŒå¿ èªæ å ±ïŒ
ãŠãŒã¬ã«ïŒor 飿³ïŒœãŒïŒïŒ@ShowkïŒâãã¡ã¯ã¿ãŒXãåœé¡(3) æ°åã³ãããŠã€ã«ã¹ã®ãæå€§ã®éçåå åã¯ããå
ç«ãã«å¯Ÿããç¡çè§£ãšç¡é¢å¿ã§ãã #note ãhttps://note.com/hecp/n/n00c411be5b18
ã»ã»ã»
ïŒé¢é£æ å ±ïŒ
ãŠãŒã¬ã«ïŒor飿³ïŒœãŒïŒïŒãæŽæ¿ã®æåœïŒæ¿æ²»çïŸïŸïŸïŸïŸïŸããããé£åž¯ïŸïŸïŸïŸïœµïŸïœšïœœïŸïŸããªãå±çž(Potenz)ã®ããªãã©ã«å ±åããžè±åºãæãããããã³ïŒïŒïŒãæåœã®çäŒŒå®ææ§ããšãæŽæ¿ã®æ¡ä»¶ãã«é¢ããè«èïŒCf.å°åºé¢è²Žå·³806æ¥çµïŒæåïŒ #note ãhttps://note.com/toxandoria2/n/n71729a662785
ãŠãŒã¬ã«ïŒor飿³ïŒœãŒïŒïŒãâéïŒïŒïŒŽçâèå¯ãæ°ã³ãããã³ãããã¯Â«è©Šç·ŽÂ»ã®æçŸ©ã¯ã倧âå ¬çåµåâæä»£ïŒã°ããŒãã«åœå®¶ä¿¡èªãªã¹ã¯çºçïŒã®å ã«ããçã®èª²é¡ã®çºèŠãšããããšãhttps://note.com/toxandoria2/n/n7d3053f1cf1b
ãŠãŒã¬ã«ïŒor飿³ïŒœãŒïŒïŒãä¿¡çšããªãè¯ãå¹»æ³ãèæ§äžçãæµ®éããæªãå¹»æ³ãå æããã«ã®ã¯ãäžåæ§ã®åºäŒããçµ¶ãã倿§ã«ç¹ãçåœãšèªç¶ç°å¢ãžã®çæ¬ã®å¿µïŒ #note ãhttps://note.com/toxandoria2/n/n86b34c354efb
ãŠãŒã¬ã«ïŒor飿³ïŒœãŒ4ïŒãå®éšå»åŠçãªæèå®éšãã¢ã³ããé節ãšããžã§ããã£ãã¯çŸæ£ããšãã¢ãã·ã³ãŸãŒåãã©ã³ã¹ãªãã¯ã¹å±€ãªã¢ã«å転ããªããŒãç°åžžçºçŸãçãã«å¯Ÿãããäžã€ã®åŠæ¹ã®æ¹åæ§ã #note ãhttps://note.com/toxandoria2/n/nba47ae28eff6
ã»ã»ã»ïŒ»ç·æ¥å¯çš¿ïŒâéå»ã®é¢šéªâã®å
ç«èšæ¶ãæ°åã³ããããäžçãæãïŒ
6å2020.06.19ãåèäžïŒåœç«ææçç ç©¶æå®¢å¡ç ç©¶å¡ãæ±äº¬çç§å€§åŠåèªææïŒœhttps://bio.nikkeibp.co.jp/atcl/news/p1/20/06/18/07102/ã®è»¢èŒã»ã»ã»
æ°åã³ãããŠã€ã«ã¹ææçïŒCOVD-19ïŒã®ãã³ãããã¯ãç¶ããŠãããã幟ã€ãã®åœã§ã¯ç¬¬1æ³¢ã¯çå®ã«åæã«åãã£ãŠãããå®å šã«åæããåœãåºãŠããŠãããããããã®åœã§ã®ææçãæ»äº¡çãªã©ãåºæã£ããšããã§ãæ¥æ¬ãæ±åã¢ãžã¢ã§ã®æ»äº¡çãæ¬§ç±³ãåç±³ã«æ¯èŒããŠ2æ¡å°ãªãããšã泚ç®ããããã®èæ¯ãšããŠå¹Ÿã€ãã®å¯èœæ§ã瀺åãããŠãæ€èšŒãå§ãŸãããšããŠããã
ããã®1ã€ã¯ãBCGã¯ã¯ãã³ã®æ¥çš®ãäœããã®åœ¹å²ãæãããŠããã®ã§ã¯ãªãããšã®èãã§ãããå¥ã®1ã€ã¯ããŠã€ã«ã¹æåã®æç€ºã«é¢äžããŠããããçœè¡çæåïŒHLAïŒã®éãã«ããã®ã§ã¯ãªãããšããèãã§ãããã©ã¡ããããåŸã仮説ã§ã¯ããããå人çã«ããé«ãå¯èœæ§ãæã£ã仮説ãšããŠãå æ¥å ±åãããã亀ååå¿æ§T现èãã«ããå ç«èšæ¶ã«ã€ããŠç޹ä»ãšèå¯ããããã
ãå
æ¥ã®èšäºã§ç޹ä»ããããã«ãCellèªã«å
¬è¡šããããç±³La Jolla Institute for Immunologyã®ç ç©¶è
ã«ãããã¬ããªã³ãã®è«æã«ããã°ããæ°åã³ãããŠã€ã«ã¹ïŒSARS-CoV-2ïŒæµè¡åã®å¥åº·äººã®40ïŒ
ãã60ïŒ
ã«ã¯SARS-CoV-2ã®4ã€ã®èçœè³ªãèªèããT现èã®å
ç«èšæ¶ãæç«ããŠããããŸããæµè¡åã®å
šãŠã®ããã®T现èã«ããããã颚éªïŒcommon coldïŒã®åå ãšããŠç¥ããã4çš®ã®ã³ãããŠã€ã«ã¹ã®ãã¡ãå°ãªããšã3çš®ã«äº€ååå¿æ§ã瀺ãããããšå ±åããããããããäºå®ã¯ãéçæ¥æ§åŒåžåšçå矀ïŒSARSïŒãäžæ±åŒåžåšçå矀ïŒMERSïŒã«ããææçã§ã¯æ³šç®ãããããšã®ç¡ãã£ããã³ãããŠã€ã«ã¹ã®ä»²éïŒå±ïŒãåºãèªèããã亀ååå¿æ§ã¡ã¢ãªãŒT现èãã®ååšã瀺åããéèŠãªçºèŠã§ããããã«æããã
ãã€ãŸããããããããšã ãæã
人é¡ã¯äžçã®éã«äœåãç¹°ãè¿ã颚éªãã²ããŠã倧æµã®å Žåã¯è»œãçç¶ã§å埩ããã颚éªã®åå ãŠã€ã«ã¹ãšããŠã¯ã4çš®ã®ïŒå£ç¯æ§ïŒã³ãããŠã€ã«ã¹ãããããšãåãã£ãŠãããããã4çš®ã®ã³ãããŠã€ã«ã¹ã«ç¹°ãè¿ãææããããšã«ãã£ãŠãã»ãšãã©å
šãŠã®ãããã³ãããŠã€ã«ã¹å±ã«å¯Ÿããå
ç«ãç²åŸããŠããå¯èœæ§ãé«ãããããŠãé·æéã«ããã£ãŠç¹°ãè¿ãææããããšã«ãã£ãŠãããã«ãã£ãŠã¯é¢šéªã®ã³ãããŠã€ã«ã¹ã«å
±éã®äœããã®æåãèªèãããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããç²åŸããŠããå¯èœæ§ããããšããããã ã
ããã®ãããªã³ãããŠã€ã«ã¹ãèªèãããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èãã®ååšãåæã«èãããšãæ§ã ãªçŸè±¡ã説æããããšãã§ããã
ããã®1ã€ããSARS-CoV-2ã®ææåŸã«èªå°ãããå ç«å¿çã«é¢ããŠãIgGæäœãIgMæäœãšåæã«åºçŸãããšããçŸè±¡ã ãéåžžã®å ç«å¿çã§ã¯ããŸãIgMæäœãåºçŸãããã®åŸã«IgGæäœãåºçŸããã®ã§ãCOVID-19ã§ã¯äœãç°åžžãªå ç«å¿çãèµ·ãã£ãŠããã®ã§ã¯ãªãããšã®äž»åŒµãŸã§åºãŠããã
ããã ããããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããååšããŠããŠãSARS-CoV-2ãžã®ææã«ãã£ãŠéå»ã«ææãã颚éªã®ã³ãããŠã€ã«ã¹ãžã®å ç«èšæ¶ãåŒã³èµ·ããããŠãIgGæäœãIgMæäœãšåæã«åºçŸãããšèããã°ãããæ®éã®æäœå¿çãèµ·ãã£ãŠããããšã«ãªããèåãäœããã®çŸç ã«ãã£ãŠå ç«äžå šã®ç¶æ ã«ãªã£ãŠããããã§ã¯ããã®ãããªãåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããç¡ããªã£ãããæŽ»æ§ãäœäžããŠããããã«ãèºçã®éçåãèµ·ãã£ãŠããå¯èœæ§ãé«ãã
ããŸããå°å ãSARS-CoV-2ã«ææãã«ãããšããçŸè±¡ãåæ§ã ãå°å ãææãã«ããçç±ãšããŠãå°å ã®è¡ç®¡ã¯åè硬åãªã©ãèµ·ãããŠãããå¥åžžã§ããããš ãSARS-CoV-2ã®å容äœã§ããACE2ã®çºçŸãäœãããšãæè¿å ±åãããŠããã
ããã ããããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããååšããŠããã®ã§ããã°ãå¥åžžãªè¡ç®¡ãå容äœã®äœçºçŸã«å ããŠã颚éªãç¹°ãè¿ããŠã²ããŠããéããªãææã®å°å ãè¥å¹Žè ã§ã¯çŽã¡ã«ãåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããåŒã³èµ·ããããSARS-CoV-2ãæé€ã§ããã®ãããããªãã
ããã®äº€ååå¿æ§T现èã®ååšããç«åŠçã«æµè¡åœã«ããææã®æ¡å€§ã®éããæ»äº¡çã®éããªã©ã«ãã©ã®ããã«é¢ãã£ãŠããã®ããè峿·±ããšããã ãããããã®åœãå°åã«ãã£ãŠãéå»ã«4çš®ã®ãã¡ãã©ã®ã³ãããŠã€ã«ã¹ãæµè¡ãããããŸããçŸåšãåžäžã«ååšããŠããããªã©ã«ãã£ãŠãSARS-CoV-2ãèªèã§ãã亀ååå¿æ§T现èã®éãæŽ»æ§ãç°ãªãå¯èœæ§ãããã
ãå Žåã«ãã£ãŠã¯ãæ¥æ¬ãæ±åã¢ãžã¢ã§ã¯ãSARS-CoV-2ãèªèã§ãããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããèªå°ãããããªé¢šéªã®ã³ãããŠã€ã«ã¹ã®æµè¡ãéå»ã«ãã£ãŠã欧米ãåç±³ã§ã¯ãããããã³ãããŠã€ã«ã¹ã®æµè¡ãç¡ãã£ãã®ãããããªããæ¥æ¬ãæ±åã¢ãžã¢ã欧米ãåç±³ã®SARS-CoV-2ææè ã®ãªã³ãçãæ¡åããŠã4çš®ã®ã³ãããŠã€ã«ã¹ã«å¯Ÿããå ç«åå¿ã調ã¹ãããšã«ãã£ãŠããã®å¯èœæ§ãæ€èšŒã§ããã ããã
ãããã®é¢šéªã®åå ãšãªãã³ãããŠã€ã«ã¹ãèªèãããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èãã«ã€ããŠèããŠãããããã®ãããªããã®ãåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èãã¯ããã³ãã€ããªã©ãããã®ã³ãããŠã€ã«ã¹ã«ãã£ãŠãåºæ¿ãåãç¶ããŠããå¯èœæ§ããããçŸåšããèªç¶çã«ååšããèšå€§ãªçš®é¡ã®ã³ãããŠã€ã«ã¹ãšäººé¡ãšã®çžäºäœçšããããã¯æŠãããéãã«ç¶ããŠããã¯ãã§ãããããã®å®æ ã¯ã»ãšãã©åãã£ãŠããªãã
ããåºå亀ååå¿æ§ã¡ã¢ãªãŒT现èããèªå°ããã³ãããŠã€ã«ã¹ã«å
±éã®æåãåå®ããããšãã§ããã°ããã®æåãçšããŠããããã³ãããŠã€ã«ã¹ã«æå¹ãªçæ³çãªã¯ã¯ãã³ãéçºã§ãããšæãããããã®ãããªã¯ã¯ãã³ãããå®çŸããã°ãå°æ¥ããææåã®åŒ·ãããããã¯ãèŽæ»æ§ã®é«ãæ°ããªã³ãããŠã€ã«ã¹ãåºçŸããŠãã人é¡ã¯å¯ŸåŠã§ããã¯ãã§ããã
å®ïŒœ




